Efficacy and Safety of Intralesional Triamcinolone Acetonide Injection in the Treatment of Alopecia Areata

    Esraa Wathab Abdel Fatah, Ahmed Said Abdel Shafy, Shrook A. Khashaba
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Studysummary This study observed that intralesional Triamcinolone acetonide injections were generally safe and effective for alopecia areata, with most patients experiencing good hair growth responses, though side effects like pain and atrophy were noted.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the efficacy and safety of intralesional Triamcinolone acetonide injections in treating alopecia areata (AA) in 36 patients. The treatment involved injecting 5 mg/ml of Triamcinolone acetonide every 4 weeks, with clinical assessments conducted monthly. Results showed that 5.6% of patients had an excellent response, 5.6% had a very good response, 55.6% had a good response, 5.6% had a moderate response, 16.7% had a mild response, and four patients had a poor response. Side effects were minimal, including pain and atrophy in 11.1% of patients. The study concluded that intralesional Triamcinolone acetonide injection was a safe and effective treatment for AA.
    Discuss this study in the Community →